FN1 and brain inflammatory disease: By contrast, the administration of an anti-VLA-4 antibody attenuated experimental T. cruzi–driven brain inflammation, since it abrogated T-cell influx towards neuroendocrine tissues by blocking VLA-4/VCAM-1 and VLA-4/fibronectin interactions (Roffê et al., 2003).